[ISIS-2--a study of patients with myocardial infarction. A combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke].
D001241:Aspirin / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000209:etiology*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence; D012307:Risk Factors; D013300:Streptokinase / Q000627:therapeutic use*
D013300:Streptokinase; D001241:Aspirin
ISIS-2--en studie av hjärtinfarktpatienter. Kombination av streptokinas och acetylsalicylsyra minskar risken för död, reinfarkt och stroke.